287 related articles for article (PubMed ID: 15051634)
1. Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham Risk Scores.
Ridker PM; Cook N
Circulation; 2004 Apr; 109(16):1955-9. PubMed ID: 15051634
[TBL] [Abstract][Full Text] [Related]
2. High-sensitivity C-reactive protein is associated with the risk of coronary heart disease as estimated by the Framingham Risk Score in middle-aged Japanese men.
Otsuka T; Kawada T; Katsumata M; Ibuki C; Kusama Y
Int J Cardiol; 2008 Sep; 129(2):245-50. PubMed ID: 17997174
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of combined high-sensitive C-reactive protein and N-terminal-probrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease.
Huang PH; Lu TM; Wu TC; Lin FY; Chen YH; Chen JW; Lin SJ
Coron Artery Dis; 2008 May; 19(3):187-93. PubMed ID: 18418236
[TBL] [Abstract][Full Text] [Related]
4. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.
Ridker PM; Rifai N; Rose L; Buring JE; Cook NR
N Engl J Med; 2002 Nov; 347(20):1557-65. PubMed ID: 12432042
[TBL] [Abstract][Full Text] [Related]
5. N-terminal brain natriuretic peptide predicted cardiovascular events stronger than high-sensitivity C-reactive protein in hypertension: a LIFE substudy.
Olsen MH; Wachtell K; Nielsen OW; Hall C; Wergeland R; Ibsen H; Kjeldsen SE; Devereux RB; Dahlöf B; Hildebrandt PR
J Hypertens; 2006 Aug; 24(8):1531-9. PubMed ID: 16877955
[TBL] [Abstract][Full Text] [Related]
6. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease.
Nozaki T; Sugiyama S; Koga H; Sugamura K; Ohba K; Matsuzawa Y; Sumida H; Matsui K; Jinnouchi H; Ogawa H
J Am Coll Cardiol; 2009 Aug; 54(7):601-8. PubMed ID: 19660689
[TBL] [Abstract][Full Text] [Related]
7. High sensitivity C-reactive protein in cardiovascular risk assessment. CRP mania or useful screening?
Sellmayer A; Limmert T; Hoffmann U
Int Angiol; 2003 Mar; 22(1):15-23. PubMed ID: 12771851
[TBL] [Abstract][Full Text] [Related]
8. High-sensitivity C-reactive protein: clinical importance.
Bassuk SS; Rifai N; Ridker PM
Curr Probl Cardiol; 2004 Aug; 29(8):439-93. PubMed ID: 15258556
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular risk prediction by N-terminal pro brain natriuretic peptide and high sensitivity C-reactive protein is affected by age and sex.
Olsen MH; Hansen TW; Christensen MK; Gustafsson F; Rasmussen S; Wachtell K; Ibsen H; Torp-Pedersen C; Hildebrandt PR
J Hypertens; 2008 Jan; 26(1):26-34. PubMed ID: 18090537
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
[TBL] [Abstract][Full Text] [Related]
11. Impact of traditional and novel risk factors on the relationship between socioeconomic status and incident cardiovascular events.
Albert MA; Glynn RJ; Buring J; Ridker PM
Circulation; 2006 Dec; 114(24):2619-26. PubMed ID: 17116764
[TBL] [Abstract][Full Text] [Related]
12. C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany.
Koenig W; Löwel H; Baumert J; Meisinger C
Circulation; 2004 Mar; 109(11):1349-53. PubMed ID: 15023871
[TBL] [Abstract][Full Text] [Related]
13. Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor Trial.
Morrow DA; de Lemos JA; Sabatine MS; Wiviott SD; Blazing MA; Shui A; Rifai N; Califf RM; Braunwald E
Circulation; 2006 Jul; 114(4):281-8. PubMed ID: 16847150
[TBL] [Abstract][Full Text] [Related]
14. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?
Ridker PM; Wilson PW; Grundy SM
Circulation; 2004 Jun; 109(23):2818-25. PubMed ID: 15197153
[TBL] [Abstract][Full Text] [Related]
15. High-sensitivity C-reactive protein is only weakly related to cardiovascular damage after adjustment for traditional cardiovascular risk factors.
Olsen MH; Christensen MK; Hansen TW; Gustafsson F; Rasmussen S; Wachtell K; Borch-Johnsen K; Ibsen H; Jørgensen T; Hildebrandt P
J Hypertens; 2006 Apr; 24(4):655-61. PubMed ID: 16531793
[TBL] [Abstract][Full Text] [Related]
16. Additive value of immunoassay-measured fibrinogen and high-sensitivity C-reactive protein levels for predicting incident cardiovascular events.
Mora S; Rifai N; Buring JE; Ridker PM
Circulation; 2006 Aug; 114(5):381-7. PubMed ID: 16864722
[TBL] [Abstract][Full Text] [Related]
17. C-reactive protein: a nontraditional serum marker of cardiovascular risk.
de Ferranti SD; Rifai N
Cardiovasc Pathol; 2007; 16(1):14-21. PubMed ID: 17218210
[TBL] [Abstract][Full Text] [Related]
18. Independent prognostic value of elevated high-sensitivity C-reactive protein in chronic heart failure.
Yin WH; Chen JW; Jen HL; Chiang MC; Huang WP; Feng AN; Young MS; Lin SJ
Am Heart J; 2004 May; 147(5):931-8. PubMed ID: 15131554
[TBL] [Abstract][Full Text] [Related]
19. Blood pressure, C-reactive protein, and risk of future cardiovascular events.
Blake GJ; Rifai N; Buring JE; Ridker PM
Circulation; 2003 Dec; 108(24):2993-9. PubMed ID: 14638538
[TBL] [Abstract][Full Text] [Related]
20. Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study.
Kiechl S; Willeit J; Mayr M; Viehweider B; Oberhollenzer M; Kronenberg F; Wiedermann CJ; Oberthaler S; Xu Q; Witztum JL; Tsimikas S
Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1788-95. PubMed ID: 17541022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
